Skip Navigation LinksSkip Navigation Links
Centers for Disease Control and Prevention
Safer Healthier People
Blue White
Blue White
bottom curve
CDC Home Search Health Topics A-Z spacer spacer
spacer
Blue curve MMWR spacer
spacer
spacer

The content on this page is being archived for historic and reference purposes only. The content, links, and pdfs are no longer maintained and might be outdated.

Recommendations of the Immunization Practices Advisory Committee Update: Prevention of Haemophilus influenzae Type b Disease

On June 23, 1987, the Immunization Practices Advisory Committee (ACIP) reviewed preliminary postmarketing surveillance data presented at an April 20, 1987, FDA workshop on Haemophilus influenzae type b (Hib) polysaccharide vaccines (see article below). These data were evaluated in light of the current ACIP recommendations for use of the vaccine (1) and for prophylaxis with rifampin (2) in the prevention of invasive Hib disease.

The ACIP believes that the preliminary data from these ongoing studies do not indicate a need for changes in the present recommendations for vaccine use. It should be emphasized that vaccination is not a substitute for prophylaxis with rifampin in children exposed to Hib disease.

References

  1. Immunization Practices Advisory Committee. Polysaccharide vaccine for prevention of Haemophilus influenzae type b disease. MMWR 1985;34:201-5. 2. Immunization Practices Advisory Committee. ACIP: update:

prevention of Haemophilus influenzae type b disease. MMWR 1986;35:170-4,179-80.

Disclaimer   All MMWR HTML documents published before January 1993 are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

**Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.

Page converted: 08/05/98

HOME  |  ABOUT MMWR  |  MMWR SEARCH  |  DOWNLOADS  |  RSSCONTACT
POLICY  |  DISCLAIMER  |  ACCESSIBILITY

Safer, Healthier People

Morbidity and Mortality Weekly Report
Centers for Disease Control and Prevention
1600 Clifton Rd, MailStop E-90, Atlanta, GA 30333, U.S.A

USA.GovDHHS

Department of Health
and Human Services

This page last reviewed 5/2/01